Total Payments
$475.24
2021 Payments
$50.59
Companies
6
Transactions
19
Medicare Patients
2,922
Medicare Billing
$209,663
Payment Breakdown by Category
Food & Beverage$475.24 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $475.24 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $195.22 | 8 | $0 (2021) |
| Aerie Pharmaceuticals, Inc. | $136.32 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $64.36 | 4 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $30.61 | 2 | $0 (2018) |
| Shire North American Group Inc | $29.38 | 2 | $0 (2018) |
| Akorn Inc. | $19.35 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $50.59 | 3 | Allergan, Inc. ($33.84) |
| 2020 | $149.93 | 5 | Allergan, Inc. ($137.60) |
| 2019 | $16.03 | 1 | Novartis Pharmaceuticals Corporation ($16.03) |
| 2018 | $193.34 | 6 | Aerie Pharmaceuticals, Inc. ($136.32) |
| 2017 | $65.35 | 4 | Akorn Inc. ($19.35) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/01/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/02/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/26/2020 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: GLAUCOMA | ||||||
| 09/24/2020 | Allergan, Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: DRY EYE | ||||||
| 09/10/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/27/2020 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/05/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $92.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/21/2019 | Novartis Pharmaceuticals Corporation | TRAVATAN Z (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/01/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | BEPREVE (Drug), LOTEMAX GEL | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/13/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $114.16 | General |
| Category: Ophthalmology | ||||||
| 08/30/2018 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/24/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Ophthalmology | ||||||
| 04/16/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: OPTHALMICS | ||||||
| 01/16/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | BESIVANCE (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/14/2017 | Akorn Inc. | Zioptan (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Ophthalmology | ||||||
| 06/06/2017 | Novartis Pharmaceuticals Corporation | SIMBRINZA (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/25/2017 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: DRY EYE | ||||||
| 03/06/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: OPTHALMICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 9 | 1,372 | 1,588 | $373,860 | $99,575 |
| 2020 | 8 | 1,550 | 1,744 | $399,485 | $110,088 |
Total Patients
2,922
Total Services
3,332
Medicare Billing
$209,663
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 518 | 545 | $152,600 | $45,152 | 29.6% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 253 | 400 | $100,060 | $23,819 | 23.8% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 113 | 113 | $33,070 | $10,887 | 32.9% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 124 | 131 | $15,720 | $5,948 | 37.8% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 149 | 171 | $27,360 | $5,154 | 18.8% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 133 | 146 | $23,360 | $3,719 | 15.9% |
| 66821 | Removal of recurring cataract in lens capsule using laser | Office | 2021 | 12 | 12 | $14,000 | $3,264 | 23.3% |
| 92020 | Examination of cornea and iris using lens device and slit lamp | Office | 2021 | 52 | 52 | $3,640 | $853.53 | 23.4% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2021 | 18 | 18 | $4,050 | $777.55 | 19.2% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 622 | 629 | $176,120 | $52,998 | 30.1% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 285 | 430 | $107,500 | $26,273 | 24.4% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 114 | 114 | $33,060 | $11,779 | 35.6% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 162 | 167 | $20,040 | $7,431 | 37.1% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 167 | 195 | $31,200 | $6,166 | 19.8% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 143 | 152 | $24,320 | $3,935 | 16.2% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2020 | 21 | 21 | $4,725 | $828.53 | 17.5% |
| 92020 | Examination of cornea and iris using lens device and slit lamp | Office | 2020 | 36 | 36 | $2,520 | $677.55 | 26.9% |
About Dr. Glenn Shear, M.D
Dr. Glenn Shear, M.D is a Ophthalmology healthcare provider based in Riverdale, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285644542.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glenn Shear, M.D has received a total of $475.24 in payments from pharmaceutical and medical device companies, with $50.59 received in 2021. These payments were reported across 19 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($475.24).
As a Medicare-enrolled provider, Shear has provided services to 2,922 Medicare beneficiaries, totaling 3,332 services with total Medicare billing of $209,663. Data is available for 2 years (2020–2021), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Riverdale, GA
- Active Since 08/09/2006
- Last Updated 04/25/2016
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1285644542
Products in Payments
- LUMIGAN (Drug) $141.72
- Rhopressa (Drug) $136.32
- XIIDRA (Drug) $58.46
- RESTASIS (Drug) $24.44
- Zioptan (Drug) $19.35
- SIMBRINZA (Biological) $19.25
- DURYSTA (Drug) $17.36
- BEPREVE (Drug) $17.23
- TRAVATAN Z (Drug) $16.03
- BESIVANCE (Drug) $13.38
- COMBIGAN (Drug) $11.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Riverdale
Dr. John Miller, Md, MD
Ophthalmology — Payments: $65,934
Ophthalmology $65,934
Dr. Michael Summerfield, M.d, M.D
Ophthalmology — Payments: $46,360
Ophthalmology $46,360
Deborah Wilson, M.d, M.D
Ophthalmology — Payments: $7,831
Ophthalmology $7,831
Dr. Ricardo Akstein, M.d, M.D
Ophthalmology — Payments: $4,677
Ophthalmology $4,677
Lamees Ashker, M.d, M.D
Ophthalmology — Payments: $3,923
Ophthalmology $3,923
Mr. Paul Goodman
Ophthalmology — Payments: $508.38
Ophthalmology $508.38